Annual SG&A
$17.37 M
-$1.60 M-8.42%
31 December 2022
Summary:
Catalyst Biosciences annual selling, general & administrative expenses is currently $17.37 million, with the most recent change of -$1.60 million (-8.42%) on 31 December 2022. During the last 3 years, it has fallen by -$1.60 million (-8.42%).CBIO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.41 M
+$183.00 K+8.22%
30 September 2023
Summary:
Catalyst Biosciences quarterly selling, general & administrative expenses is currently $2.41 million, with the most recent change of +$183.00 thousand (+8.22%) on 30 September 2023.CBIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.65 B
-$44.24 M-2.76%
30 September 2023
Summary:
Catalyst Biosciences TTM selling, general & administrative expenses is currently -$1.65 billion, with the most recent change of -$44.24 million (-2.76%) on 30 September 2023.CBIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -8.4% | -42.2% | -8798.4% |
| 5 y5 years | +29.4% | -24.6% | -10000.0% |
CBIO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -8.4% | -55.5% | -8743.3% |
Catalyst Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $2.41 M(+8.2%) | $12.77 M(-13.3%) |
| June 2023 | - | $2.23 M(-44.0%) | $14.72 M(-9.9%) |
| Mar 2023 | - | $3.97 M(-4.7%) | $16.34 M(-5.9%) |
| Dec 2022 | $17.37 M(-8.4%) | $4.17 M(-4.5%) | $17.37 M(+0.0%) |
| Sept 2022 | - | $4.36 M(+13.5%) | $17.36 M(-2.8%) |
| June 2022 | - | $3.84 M(-23.0%) | $17.87 M(-3.6%) |
| Mar 2022 | - | $4.99 M(+19.9%) | $18.55 M(-2.2%) |
| Dec 2021 | $18.96 M(+17.2%) | $4.16 M(-14.5%) | $18.96 M(-0.6%) |
| Sept 2021 | - | $4.87 M(+7.8%) | $19.08 M(+5.7%) |
| June 2021 | - | $4.52 M(-16.5%) | $18.05 M(+0.8%) |
| Mar 2021 | - | $5.41 M(+26.3%) | $17.90 M(+10.6%) |
| Dec 2020 | $16.18 M(+20.6%) | $4.29 M(+11.8%) | $16.18 M(+7.2%) |
| Sept 2020 | - | $3.83 M(-12.3%) | $15.09 M(+3.9%) |
| June 2020 | - | $4.37 M(+18.4%) | $14.52 M(+8.2%) |
| Mar 2020 | - | $3.69 M(+15.6%) | $13.42 M(+0.0%) |
| Dec 2019 | $13.42 M(+8.6%) | $3.19 M(-2.3%) | $13.42 M(-1.8%) |
| Sept 2019 | - | $3.27 M(-0.1%) | $13.67 M(+3.8%) |
| June 2019 | - | $3.27 M(-11.3%) | $13.17 M(+0.3%) |
| Mar 2019 | - | $3.69 M(+7.0%) | $13.13 M(+6.3%) |
| Dec 2018 | $12.35 M(+23.6%) | $3.44 M(+24.4%) | $12.35 M(+7.5%) |
| Sept 2018 | - | $2.77 M(-14.1%) | $11.49 M(+3.4%) |
| June 2018 | - | $3.23 M(+10.7%) | $11.12 M(+5.4%) |
| Mar 2018 | - | $2.91 M(+12.7%) | $10.54 M(+5.3%) |
| Dec 2017 | $9.99 M(+7.9%) | $2.59 M(+8.2%) | $10.01 M(+4.2%) |
| Sept 2017 | - | $2.39 M(-9.9%) | $9.61 M(-0.4%) |
| June 2017 | - | $2.65 M(+11.5%) | $9.64 M(+4.1%) |
| Mar 2017 | - | $2.38 M(+9.3%) | $9.26 M(-0.2%) |
| Dec 2016 | $9.26 M(-3.5%) | $2.18 M(-10.1%) | $9.27 M(-8.4%) |
| Sept 2016 | - | $2.42 M(+6.7%) | $10.12 M(-0.8%) |
| June 2016 | - | $2.27 M(-5.1%) | $10.20 M(-4.4%) |
| Mar 2016 | - | $2.40 M(-20.9%) | $10.68 M(-8.5%) |
| Dec 2015 | $9.59 M(-5.7%) | $3.03 M(+20.7%) | $11.67 M(+7.8%) |
| Sept 2015 | - | $2.51 M(-8.7%) | $10.83 M(+1.4%) |
| June 2015 | - | $2.75 M(-18.9%) | $10.68 M(-1.1%) |
| Mar 2015 | - | $3.39 M(+55.1%) | $10.80 M(+6.1%) |
| Dec 2014 | $10.17 M(-15.3%) | $2.18 M(-7.4%) | $10.17 M(-4.4%) |
| Sept 2014 | - | $2.36 M(-17.8%) | $10.63 M(-4.3%) |
| June 2014 | - | $2.87 M(+3.8%) | $11.11 M(-1.5%) |
| Mar 2014 | - | $2.76 M(+4.4%) | $11.28 M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $12.01 M(-9.0%) | $2.65 M(-6.6%) | $12.01 M(-3.7%) |
| Sept 2013 | - | $2.83 M(-6.6%) | $12.46 M(+3.3%) |
| June 2013 | - | $3.03 M(-13.1%) | $12.06 M(-11.4%) |
| Mar 2013 | - | $3.49 M(+12.4%) | $13.61 M(+3.2%) |
| Dec 2012 | $13.19 M(+8.4%) | $3.10 M(+27.6%) | $13.19 M(+0.6%) |
| Sept 2012 | - | $2.43 M(-47.0%) | $13.11 M(-3.0%) |
| June 2012 | - | $4.59 M(+49.4%) | $13.52 M(+12.1%) |
| Mar 2012 | - | $3.07 M(+1.6%) | $12.06 M(-0.9%) |
| Dec 2011 | $12.17 M(+51.1%) | $3.02 M(+6.3%) | $12.17 M(+5.7%) |
| Sept 2011 | - | $2.84 M(-9.2%) | $11.51 M(+7.4%) |
| June 2011 | - | $3.13 M(-1.4%) | $10.72 M(+14.0%) |
| Mar 2011 | - | $3.17 M(+34.3%) | $9.40 M(+16.8%) |
| Dec 2010 | $8.05 M(-1.4%) | $2.36 M(+15.2%) | $8.05 M(-14.1%) |
| Sept 2010 | - | $2.05 M(+13.1%) | $9.38 M(+4.7%) |
| June 2010 | - | $1.81 M(-0.4%) | $8.95 M(+5.1%) |
| Mar 2010 | - | $1.82 M(-50.6%) | $8.52 M(+4.3%) |
| Dec 2009 | $8.17 M(+25.7%) | $3.69 M(+126.7%) | $8.16 M(+36.3%) |
| Sept 2009 | - | $1.63 M(+18.2%) | $5.99 M(+4.0%) |
| June 2009 | - | $1.38 M(-6.3%) | $5.76 M(-8.2%) |
| Mar 2009 | - | $1.47 M(-3.1%) | $6.28 M(-3.4%) |
| Dec 2008 | $6.50 M(-18.9%) | $1.52 M(+8.6%) | $6.50 M(-8.6%) |
| Sept 2008 | - | $1.40 M(-26.2%) | $7.11 M(-6.8%) |
| June 2008 | - | $1.89 M(+12.0%) | $7.63 M(-8.8%) |
| Mar 2008 | - | $1.69 M(-20.5%) | $8.37 M(+4.4%) |
| Dec 2007 | $8.01 M(+40.7%) | $2.13 M(+10.8%) | $8.01 M(+1.9%) |
| Sept 2007 | - | $1.92 M(-27.0%) | $7.86 M(+9.8%) |
| June 2007 | - | $2.63 M(+96.4%) | $7.16 M(+22.1%) |
| Mar 2007 | - | $1.34 M(-32.3%) | $5.87 M(+3.0%) |
| Dec 2006 | $5.70 M(-10.8%) | $1.98 M(+61.8%) | $5.70 M(-12.2%) |
| Sept 2006 | - | $1.22 M(-8.3%) | $6.49 M(+1.0%) |
| June 2006 | - | $1.33 M(+14.0%) | $6.43 M(+1.2%) |
| Mar 2006 | - | $1.17 M(-57.8%) | $6.35 M(-0.6%) |
| Dec 2005 | $6.39 M(+23.7%) | $2.77 M(+138.9%) | $6.39 M(+76.4%) |
| Sept 2005 | - | $1.16 M(-7.6%) | $3.62 M(+47.1%) |
| June 2005 | - | $1.25 M(+3.7%) | $2.46 M(+103.7%) |
| Mar 2005 | - | $1.21 M | $1.21 M |
| Dec 2004 | $5.16 M(+43.4%) | - | - |
| Dec 2003 | $3.60 M(-12.9%) | - | - |
| Dec 2002 | $4.13 M(+79.6%) | - | - |
| Dec 2001 | $2.30 M | - | - |
FAQ
- What is Catalyst Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Catalyst Biosciences?
- What is Catalyst Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Catalyst Biosciences?
What is Catalyst Biosciences annual selling, general & administrative expenses?
The current annual SG&A of CBIO is $17.37 M
What is the all time high annual SG&A for Catalyst Biosciences?
Catalyst Biosciences all-time high annual selling, general & administrative expenses is $18.96 M
What is Catalyst Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of CBIO is $2.41 M
What is the all time high quarterly SG&A for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly selling, general & administrative expenses is $5.41 M
What is Catalyst Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of CBIO is -$1.65 B
What is the all time high TTM SG&A for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM selling, general & administrative expenses is $19.08 M